Dogs (at least 7 weeks of age and 3 lbs +)

Imoxi Topical Solution for Dogs is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and the treatment of Dirofilaria immitis circulating microfilariae in heartworm-positive dogs. IMOXI Topical Solution for Dogs kills adult fleas and is indicated for the treatment of flea infestations (Ctenocephalides felis). IMOXI Topical Solution for Dogs is indicated for the treatment and control of sarcoptic mange caused by Sarcoptes scabiei var. canis. IMOXI Topical Solution for Dogs is also indicated for the treatment and control of the following intestinal parasites: Ancylostoma caninum, Uncinaria stenocephala, Toxocara canis, Toxascaris leonina, Trichuris vulpis.Imoxi Topical Solution offers proven protection against a broad spectrum of parasites at an affordable price. No pet should be vulnerable to fleas, heartworms, or intestinal parasites. Imoxi Topical Solution is a generic prescription topical combination that's proven effective for broad-spectrum prevention at a price that's easy on pet owners. Transdermal moxidectin has a unique pharmacologic profile that provides benefits other formulations do not: The only heartworm preventive formulation to be FDA approved as safe and effective for dogs with circulating microfilariae 1 Month-long protection from heartworm disease2 Imoxi kills newly acquired heartworm larvae, each day, and through the entire month

Vetoquinol

Moxidectin and imidacloprid

Sold as 6 pack box for the following dog weights : 3-9 lbs, 9.1-20 lbs, 20.1-55 lbs, 55.1-88 lbs, or 88.1-110 lbs.

Causes eye irritation. Harmful if swallowed. Do not get in eyes or on clothing. Avoid contact with skin. Exposure to the product has been reported to cause headache; dizziness; and redness, burning, tingling, or numbness of the skin. Wash hands thoroughly with soap and warm water after handling. If contact with eyes occurs, hold eyelids open and flush with copious amounts of water for 15 minutes. If eye irritation develops or persists, contact a physician. If swallowed, call poison control center or physician immediately for treatment advice. Have person sip a glass of water if able to swallow. Do not induce vomiting unless told to do so by the poison control center or physician. People with known hypersensitivity to benzyl alcohol, imidacloprid or moxidectin should administer the product with caution. In case of allergic reaction, contact a physician. If contact with skin or clothing occurs, take off contaminated clothing. Wash skin immediately with plenty of soap and water. Call a poison control center or physician for treatment advice. The Safety Data Sheet (SDS) provides additional occupational safety information. For consumer questions call 1-800-835-9496. For a copy of the Safety Data Sheet (SDS) or to report adverse reactions call Vetoquinol USA, Inc. at 1-800-835-9496.

PRECAUTIONS: Do not dispense dose applicator tubes without complete safety and administration information. Use with caution in sick, debilitated, or underweight animals. The safety of IMOXI Topical Solution for Dogs has not been established in breeding, pregnant, or lactating dogs. The safe use of IMOXI Topical Solution for Dogs has not been established in puppies and dogs less than 7 weeks of age or less than 3 lbs. body weight. Prior to administration of IMOXI Topical Solution for Dogs, dogs should be tested for existing heartworm infection. At the discretion of the veterinarian, infected dogs should be treated with an adulticide to remove adult heartworms. The safety of IMOXI Topical Solution for Dogs has not been evaluated when administered on the same day as an adulticide. IMOXI Topical Solution for Dogs is not effective against adult D. immitis. Although the number of circulating microfilariae is substantially reduced in most dogs following treatment with IMOXI Topical Solution for Dogs, the microfilaria count in some heartworm-positive dogs may increase or remain unchanged following treatment with IMOXI Topical Solution for Dogs, alone or in a dosing regimen with melarsomine dihydrochloride. (See ADVERSE REACTIONS and ANIMAL SAFETY – Safety Study in Heartworm-Positive Dogs.) IMOXI Topical Solution for Dogs has not been evaluated in heartworm-positive dogs with Class 4 heartworm disease. CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Dogs: WARNING: DO NOT ADMINISTER THIS PRODUCT ORALLY. For the first 30 minutes after application, ensure that dogs cannot lick the product from application sites on themselves or other treated animals. Children should not come in contact with the application sites for two (2) hours after application. (See Contraindications, Warnings, Human Warnings and Adverse Reactions for more information.) For full prescribing information, visit www.vetoquinolusa.com/imoxi-info. Freedom of Information Summary. NADA 141-251 Supplement. Oct. 24, 2013. Bowman, D.D., Ohmes, C.M., Hostetler, J.A. et al. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi® for Dogs) for the prevention of heartworm disease and infection all month long. Parasites Vectors 10, 478 (2017).

Contact your nearest emergency animal hospital.

Store at temperatures between 20º C (68 °F) and 25º C (77 °F), avoiding excess heat or cold